Skinvisible (SKVI) Non-Current Assets (2010 - 2026)
Skinvisible's (SKVI) quarterly Non-Current Assets came in at $90033.0 in Q2 2026, down 18.35% year-over-year from $110273.0 in Q2 2025, and down 5.26% quarter-over-quarter from $95029.0 in Q1 2026.
Powered by 
Analysis
Skinvisible (SKVI) Non-Current Assets (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Non-Current Assets across 17 years of filings, most recently posting $90033.0 for Q2 2026.
- In Q2 2026, Non-Current Assets fell 18.35% year-over-year to $90033.0; the TTM figure through Jun 2026 stood at $390252.0 (down 14.97% YoY), while the FY2025 annual figure was $100036.0, down 13.9% from the prior year.
- Non-Current Assets came in at $90033.0 for Q2 2026 at Skinvisible, down from $95029.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $148462.0 in Q1 2022 to a low of $90033.0 in Q2 2026.
- Average Non-Current Assets over 5 years is $122235.6, with a median of $124945.0 recorded in 2024.
- Year-over-year, Non-Current Assets advanced 1.46% in 2022 and retreated 18.35% in 2026.
- Over 5 years, Non-Current Assets stood at $136847.0 in 2022, then fell by 6.9% to $127409.0 in 2023, then fell by 8.81% to $116189.0 in 2024, then fell by 13.9% to $100036.0 in 2025, then retreated by 10.0% to $90033.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $90033.0 in Q2 2026, $95029.0 in Q1 2026, and $100036.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.06 Bn | 626.30 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 440.06 Bn | 433.49 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 364.19 Bn | 357.05 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 268.45 Bn | 260.76 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Pfizer | 158.40 Bn | 146.70 Bn | 10.94 Bn | 159.77 Bn |
| 6 | Sanofi | 52.57 Bn | 45.19 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | 294.93 Mn |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn | 1.85 Bn |
| 9 | United Therapeutics | 21.15 Bn | 18.49 Bn | 683.80 Mn | 3.74 Bn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 90,033.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90,033.00 |
| Mar 31, 2026 | 95,029.00 |
| Dec 31, 2025 | 100,036.00 |
| Sep 30, 2025 | 105,154.00 |
| Jun 30, 2025 | 110,273.00 |
| Mar 31, 2025 | 111,249.00 |
| Dec 31, 2024 | 116,189.00 |
| Sep 30, 2024 | 121,239.00 |
| Jun 30, 2024 | 127,176.00 |
| Mar 31, 2024 | 122,714.00 |
| Dec 31, 2023 | 127,409.00 |
| Sep 30, 2023 | 132,156.00 |
| Jun 30, 2023 | 136,697.00 |
| Mar 31, 2023 | 132,728.00 |
| Dec 31, 2022 | 136,847.00 |
| Sep 30, 2022 | 141,060.00 |
| Jun 30, 2022 | 145,789.00 |
| Mar 31, 2022 | 148,462.00 |
| Dec 31, 2021 | 153,055.00 |
| Sep 30, 2021 | 157,750.00 |